417 related articles for article (PubMed ID: 10028430)
21. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
22. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
[TBL] [Abstract][Full Text] [Related]
23. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
24. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
[TBL] [Abstract][Full Text] [Related]
25. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment.
Nomata K; Noguchi M; Kanetake H; Tsuda N; Hayashi M; Yamashita S; Sakuragi T; Kusaba Y; Shindo K;
Cancer Chemother Pharmacol; 2002 Oct; 50(4):266-70. PubMed ID: 12357299
[TBL] [Abstract][Full Text] [Related]
26. A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
Serretta V; Morgia G; Altieri V; Di Lallo A; Ruggiero G; Salzano L; Battaglia M; Falsaperla M; Zito A; Sblendorio D; Melloni D; Allegro R;
BJU Int; 2010 Jul; 106(2):212-7. PubMed ID: 20070299
[TBL] [Abstract][Full Text] [Related]
27. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time].
Nonomura N; Nishimura K; Okuyama A; Miki T; Kishimoto T; Kiyohara H; Wakatsuki A; Fujioka H; Kuroda H; Nakano E; Takeyama M; Koide T; Yamaguchi S
Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751
[TBL] [Abstract][Full Text] [Related]
28. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
29. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer].
Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T
Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805
[TBL] [Abstract][Full Text] [Related]
30. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
[TBL] [Abstract][Full Text] [Related]
31. [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
Ikeda R; Chikazawa I; Kobayashi Y; Shiroma K; Nakade T; Suga K; Shiba N; Nakajima C; Moriyama M; Kawamura K; Miyazawa K; Tanaka T; Tsugawa R; Suzuki K; Sato H; Kikuyama A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748
[TBL] [Abstract][Full Text] [Related]
32. [Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor].
Pérez Mestre M; Cuñat Albert E; Francisco Mingol V; Arrufat Boix JM; Gallego Gómez J
Arch Esp Urol; 1999 May; 52(4):345-50. PubMed ID: 10380324
[TBL] [Abstract][Full Text] [Related]
33. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
Cervenakov I; Szoldova K; Mardiak J; Chovan D; Mala M; Slavov D
Bratisl Lek Listy; 2000; 101(6):317-20. PubMed ID: 11039202
[TBL] [Abstract][Full Text] [Related]
34. [Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence].
Sonoda T; Osafune M; Matsuda M; Usami M
Hinyokika Kiyo; 1988 Mar; 34(3):574-81. PubMed ID: 2455442
[TBL] [Abstract][Full Text] [Related]
35. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
Miki T; Nonomura N; Kojima Y; Okuyama A; Nakano E; Kiyohara H; Fujioka H; Koide T; Wakatsuki A; Kuroda H; Sugao H; Seguti T; Takeyama M; Yamaguchi S
Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944
[TBL] [Abstract][Full Text] [Related]
36. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
Liu B; Zhang Y; Wang Z; Ding Q; Chen B; Wang J; Jiang H
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
[TBL] [Abstract][Full Text] [Related]
37. [Prophylactic combination therapy after TUR of superficial bladder cancer].
Ao T; Uchida T; Yokoyama E; Kawakami T; Adachi K; Mashimo S; Endo T; Koshiba K
Hinyokika Kiyo; 1993 Nov; 39(11):987-91. PubMed ID: 7505523
[TBL] [Abstract][Full Text] [Related]
38. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
Hendricksen K; Witjes WP; Idema JG; Kums JJ; van Vierssen Trip OB; de Bruin MJ; Vergunst H; Caris CT; Janzing-Pastors MH; Witjes JA
Eur Urol; 2008 May; 53(5):984-91. PubMed ID: 18248876
[TBL] [Abstract][Full Text] [Related]
39. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
40. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
